Item 2.02 Results of Operations and Financial Condition.

On May 6, 2021, Intellia Therapeutics, Inc. announced its financial results and business updates for the quarter ended March 31, 2021. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 on this Current Report on Form 8-K.

The information in this report furnished pursuant to Item 2.02 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, if such subsequent filing specifically references the information furnished pursuant to Item 2.02 of this report.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



Exhibit
  No.     Description

99.1        Press release dated May 6, 2021  .

104       Cover Page Interactive Data File (embedded within the Inline XBRL document)



                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses